Ege Üniversitesi Hastanesi veri tabanında meme kanseri hastalarının epidemiyolojisi ve genel sağ kalım özellikleri

Amaç: Ege Üniversitesi Hastanesinde 1992-2017 arası kanser tanı ve tedavisi yapılan 13079 meme kanser tanılı hastanın genel özellikleri, tedavi modaliteleri ve sağ kalım sürelerinin tanımlanması amaçlanmıştır. Gereç ve Yöntem: Ege Üniversitesi Kanserle Savaş Araştırma ve Uygulama Merkezi tarafından toplanan meme kanseri verileri CANREG özel bilgisayar programına kayıt edilmiş, DSÖ ve SEER sistemleri temelinde gruplanarak analizler yapılmıştır. İstatistik analizlerde Ki-kare, General Linear Model, Kaplan Meier sağ kalım analizleri uygulanmıştır. Kaplan Meier Sağ kalım analizinde Log Rank (Mantel-Cox), Breslow (Generalized Wilcoxon) ve Tarone-Ware istatistikleri kullanılmıştır. İstatistik analizlerde p

Epidemiological and overall survival characteristics of breast cancer patients in Ege University Hospital database

Aim: The study aimed to define the baseline characteristics, treatment modalities and survival outcome of breast cancer patients who admitted to Ege University School of Medicine between 1992- 2017. Materials and Methods: The breast cancer patients’ data that was collected by Ege University Cancer Research Center, was recorded to CANREG computer program, and analyses was performed according to WHO and SEER system definitions. Chi-square, General Linear Model and Kaplan-Meier survival analyses was performed for further analyses. Log Rank (Mantel-Cox), Breslow (Generalized Wilcoxon) and Tarone-Ware statistics was used for survival analyses. p

PDF

___

1. Bray F, Ferlay J, Soerjomataram I and et al. Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. Cancer J Clin. 2018; 68: 394-424.

2. H ry C, Ferlay , Bon ol M, Aut er P. Changes n breast cancer nc dence and mortal ty n m ddle-aged and elderly women in 28 coun- tries with Caucasian majority populations. Ann Oncol 2008; 19 (6): 1187-94.

3. Ravdin PM, Cronin KA, Howlader N, Berg CD, Chlebowski RT, et al. The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med. 2007 Apr 19; 356 (16): 1670-4.

4. Key TJ, Verkasalo PK, Banks E. Epidemiology of breast cancer. Lancet Oncol 2001; 2 (3): 133-40.

5. Haydaroğlu A, Dubova S, Ozsaran Z, Bolukbaşı Y, et al. Ege Üniversitesinde Meme Kanserleri: 3897 Olgunun Değerlendirilmesi. Meme Sağlığı Dergisi 2005; 1 (1): 6-11.

6. Abdelwahab Yousef AJ. Male Breast Cancer: Epidemiology and Risk Factors. Semin Oncol. 2017 Aug;44(4):267- 72.

7. Çakar B, Sert F, Gürsoy P, Emekdaş B, Özsaran Z, Gökmen E, Haydaroğlu A. Long-Term Follow-Up of Patients with Male Breast Cancer, Single-Center Experience. Turk J Oncol 2019; 34 (2): 66–71.

8. Li CI. Risk of mortality by histologic type of breast cancer in the United States. Horm Cancer. 2010 Jun;1 (3): 156-65.

9. Chen MT, Sun HF, Zhao Y et al. Comparison of patterns and prognosis among distant metastatic breast cancer patients by age groups: a SEER population-based analysis. Sci Rep. 2017 Aug 23; 7 (1): 9254.